P
PERSONALIS INC
NASDAQ: PSNL (Personalis, Inc.)
Kemas kini terakhir: 20 minit lalu16.57
0.00 (0.00%)
| Penutupan Terdahulu | 16.57 |
| Jumlah Dagangan | 200,521 |
| Harga / Jualan (P/S) | 22.93 |
| Harga / Buku (P/B) | 7.43 |
| Julat 52 Minggu |
| Margin Keuntungan | -98.10% |
| Margin Operasi (TTM) | -85.88% |
| EPS Cair (TTM) | -1.29 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.81% |
| Nisbah Semasa (MRQ) | 6.91 |
| Aliran Tunai Operasi (OCF TTM) | -42.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -23.09 M |
| Pulangan Atas Aset (ROA TTM) | -17.90% |
| Pulangan Atas Ekuiti (ROE TTM) | -51.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Personalis, Inc. | Bercampur | Menaik |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.88 |
|
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 31.49% |
| % Dimiliki oleh Institusi | 46.11% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Merck & Co., Inc. | 30 Jun 2026 | 14,044,943 |
| Ark Investment Management Llc | 30 Jun 2026 | 8,271,339 |
| Lightspeed Management Company, L.L.C. | 30 Jun 2026 | 6,101,850 |
| Ameriprise Financial Inc | 30 Jun 2026 | 6,086,315 |
| Deep Track Capital, Lp | 30 Jun 2026 | 4,000,000 |
| Aberdeen Group Plc | 30 Jun 2026 | 3,747,290 |
| Casdin Capital, Llc | 30 Jun 2026 | 2,550,000 |
| Kennedy Capital Management Llc | 30 Jun 2026 | 2,364,282 |
| Aigh Capital Management Llc | 30 Jun 2026 | 1,715,000 |
| Blue Water Life Science Advisors, Lp | 30 Jun 2026 | 1,676,300 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CHEN RICHARD | - | 16.40 | -3,998 | -65,567 |
| HALL CHRISTOPHER M | - | 16.40 | -7,459 | -122,328 |
| MOORE STEPHEN MICHAEL | - | 16.40 | -2,068 | -33,915 |
| TACHIBANA AARON | - | 16.40 | -2,931 | -48,068 |
| Jumlah Keseluruhan Kuantiti Bersih | -16,456 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -269,878 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 16.40 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TACHIBANA AARON | Pegawai | 18 Sep 2026 | Jual (-) | 2,931 | 16.40 | 48,068 |
| HALL CHRISTOPHER M | Pegawai | 18 Sep 2026 | Jual (-) | 7,459 | 16.40 | 122,328 |
| MOORE STEPHEN MICHAEL | Pegawai | 18 Sep 2026 | Jual (-) | 2,068 | 16.40 | 33,915 |
| CHEN RICHARD | Pegawai | 18 Sep 2026 | Jual (-) | 3,998 | 16.40 | 65,567 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |